NCT01535677 - To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Dapagliflozin + Glucophage tablet fasted

Single oral doses of 5 mg dapagliflozin and 850 mg Glucophage® tablets administered together in the fasted state

DRUG

Dapagliflozin/metformin IR FDC tablet fasted

single oral dose of dapagliflozin/metformin (5 mg/850 mg) IR FDC tablet in the fasted state

DRUG

Dapagliflozin + Glucophage tablet fed

Single oral doses of 5 mg dapagliflozin and 850 mg Glucophage® tablets administered together in the fed state

DRUG

Dapagliflozin/metformin IR FDC tablet fed

single oral dose of dapagliflozin/metformin (5 mg/850 mg) IR FDC tablet in the fed state

Trial Locations (1)

Research Site, London